Harbour Trust & Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
7,649
-20
-0.3% -$3K 0.12% 79
2026
Q1
$1.17M Sell
7,669
-50
-0.6% -$7.66K 0.12% 81
2025
Q4
$1.06M Sell
7,719
-344
-4% -$45K 0.11% 82
2025
Q3
$1.03M Sell
8,063
-100
-1% -$12.2K 0.11% 85
2025
Q2
$988K Hold
8,163
0.11% 87
2025
Q1
$910K Sell
8,163
-1,058
-11% -$113K 0.11% 90
2024
Q4
$897K Sell
9,221
-48
-0.5% -$5.12K 0.1% 91
2024
Q3
$1.07M Sell
9,269
-300
-3% -$34K 0.12% 90
2024
Q2
$1.02M Sell
9,569
-376
-4% -$37.7K 0.12% 92
2024
Q1
$962K Sell
9,945
-150
-1% -$15.4K 0.12% 93
2023
Q4
$1.02M Buy
+10,095
New +$974K 0.14% 90

Other funds holding NVS

Harbour Trust & Investment Management's NVS Position: Q2 2026 in Review

Harbour Trust & Investment Management reduced its Novartis (NVS) stake by 0.26% in Q2 2026, selling an estimated $3K and leaving 7,649 shares worth $1.2M. The position accounts for 0.12% of the portfolio, ranked #79.

Harbour Trust & Investment Management first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. 733 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Harbour Trust & Investment Management held 7,649 shares of Novartis worth $1.2M as of Q2 2026.
  • Harbour Trust & Investment Management sold 20 Novartis shares in Q2 2026, an estimated $3K.
  • Novartis made up 0.12% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #79 holding.
  • Harbour Trust & Investment Management first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
  • 733 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.